1. Home
  2. ANDE vs SYRE Comparison

ANDE vs SYRE Comparison

Compare ANDE & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANDE
  • SYRE
  • Stock Information
  • Founded
  • ANDE 1947
  • SYRE 2013
  • Country
  • ANDE United States
  • SYRE United States
  • Employees
  • ANDE N/A
  • SYRE N/A
  • Industry
  • ANDE Farming/Seeds/Milling
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANDE Industrials
  • SYRE Health Care
  • Exchange
  • ANDE Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • ANDE 1.3B
  • SYRE 841.4M
  • IPO Year
  • ANDE N/A
  • SYRE 2016
  • Fundamental
  • Price
  • ANDE $34.41
  • SYRE $12.86
  • Analyst Decision
  • ANDE Buy
  • SYRE Buy
  • Analyst Count
  • ANDE 3
  • SYRE 8
  • Target Price
  • ANDE $51.67
  • SYRE $50.00
  • AVG Volume (30 Days)
  • ANDE 294.2K
  • SYRE 570.5K
  • Earning Date
  • ANDE 05-06-2025
  • SYRE 05-20-2025
  • Dividend Yield
  • ANDE 2.48%
  • SYRE N/A
  • EPS Growth
  • ANDE N/A
  • SYRE N/A
  • EPS
  • ANDE 3.32
  • SYRE N/A
  • Revenue
  • ANDE $11,198,429,000.00
  • SYRE N/A
  • Revenue This Year
  • ANDE $5.97
  • SYRE N/A
  • Revenue Next Year
  • ANDE $4.31
  • SYRE N/A
  • P/E Ratio
  • ANDE $9.48
  • SYRE N/A
  • Revenue Growth
  • ANDE N/A
  • SYRE N/A
  • 52 Week Low
  • ANDE $31.03
  • SYRE $10.91
  • 52 Week High
  • ANDE $55.52
  • SYRE $40.49
  • Technical
  • Relative Strength Index (RSI)
  • ANDE 37.50
  • SYRE 40.40
  • Support Level
  • ANDE $31.03
  • SYRE $14.48
  • Resistance Level
  • ANDE $38.08
  • SYRE $15.77
  • Average True Range (ATR)
  • ANDE 1.30
  • SYRE 1.02
  • MACD
  • ANDE -0.32
  • SYRE 0.03
  • Stochastic Oscillator
  • ANDE 39.86
  • SYRE 16.50

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: